DETAILS, FICTION AND CLINICAL TRIAL RECRUITMENT FOR ABBV-744 STUDY

In Section A, individuals will acquire distinctive doses and schedules of oral ABBV-744 tablet to recognize Secure dosing program. More members is going to be enrolled on the identified monotherapy dosign routine. In Section B, participants will acquire oral ruxolitinib and ABBV-744 might be provided as "add-on" therapy. In Phase C, participants wi